InsidersTradesSigma
Allugator Bioscience: directors' dealings · Finland · FIN-FSA
FI:allugator-bioscienceSE0024173637FI·FIN-FSAMcap 141M€Healthcare
Explore the full insider trade history of Allugator Bioscience, a listed issuer based in Finland. Shares trade on FI FI, under the supervision of FIN-FSA. Operating in the Healthcare sector, Allugator Bioscience has logged 2 reports. Market capitalisation: €140.7m. The latest transaction was disclosed on 19 September 2025 (Other). Among the most active insiders: Sören Bregenholt Frederiksen. Every trade is free.
2
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
0.22 €
Analyst consensus
1 analystsStrong buy
0.30 €Target 0.30 €(+34%)0.30 €
Income statement
Revenue514 k€
Net income−51.4 M€-9990.3% margin
Valuation
P/Book1.4x
Beta1.24
Balance sheet & cash
Market cap140.7 M€
Total debt43.2 M€
Free Cash Flow−157.4 M€
Debt / Equity78%
Profitability & ownership
ROA-62.9%
% insiders16.5%
% institutions1.9%
Last declaration on 19 September 2025
Declarations2 total
Executives●Other28FIN-FSA
€5,91520,823 shares@ €0.2840.0042% mcap29.7% of flow
Aktie
FI:A003S445-1·
Executives●Other33FIN-FSA
€13,97841,649 shares@ €0.33560.0099% mcap70.3% of flow
Aktie
FI:A003P440-1·
2 of 2 declarations